Physician profile
Thomas Gainey
NPI 1457734949
$374.62
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $19.36 · 2021: $33.49 · 2022: $52.38 · 2023: $67.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $125.73 | 2019 | |
| Merck Sharp & Dohme LLC | $74.21 | 2021-2023 | Verquvo, Dificid, Zerbaxa |
| Janssen Pharmaceuticals, INC | $30.99 | 2021-2022 | |
| Mylan Specialty L.P. | $27.15 | 2019 | |
| Fisher & Paykel Healthcare INC | $21.22 | 2023 | Fisher & Paykel Healthcare |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.36 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.48 | 2019 | |
| Vifor Pharma, INC. | $16.22 | 2019 | |
| Boston Scientific Corporation | $16.11 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $14.08 | 2023 | Inpefa |
| Pfizer INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gainey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.